Vekemans, Johan
International AIDS Vaccine Initiative,
United States
2025 Rank: 214627
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Virology
Rank in SubField 1: 4202 out of 217955 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 214627 | 198561 |
| Total Cites | 1277 | 1457 |
| H-index | 16 | 18 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 54 | 71 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 100 | 128 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 981 | 1083 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.35 |
| Self-Citation Percentage |
12.35%
|
|
Vekemans, Johan
International AIDS Vaccine Initiative,
United States
2024 Rank: 156045
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Virology
Rank in SubField 1: 3302 out of 204759 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 156045 | 143535 |
| Total Cites | 1660 | 1925 |
| H-index | 16 | 19 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 79 | 98 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 123 | 151 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1333 | 1470 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.31 |
| Self-Citation Percentage |
13.77%
|
|
Vekemans, Johan
V4R,
Belgium
2023 Rank: 147901
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Virology
Rank in SubField 1: 3364 out of 190396 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 147901 | 140054 |
| Total Cites | 2748 | 3078 |
| H-index | 17 | 19 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 60 | 78 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 111 | 137 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2257 | 2469 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.25 |
| Self-Citation Percentage |
10.72%
|
|
Vekemans, Johan
AstraZeneca Sweden,
Sweden
2022 Rank: 152517
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Virology
Rank in SubField 1: 3559 out of 175943 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 152517 | 144802 |
| Total Cites | 2388 | 2679 |
| H-index | 16 | 18 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 54 | 66 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 111 | 137 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1889 | 2068 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.30 |
| Self-Citation Percentage |
10.86%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.